Giving Up the Guidelines
A Qualitative Evaluation of Disrupted Prescribing of Opioid Substitution Therapy in a Rural UK County During and Following the Covid-19 Pandemic
Datos Bibliográficos
| ID | 15463561 |
|---|---|
| Autores | Tim Lewington (0009-0001-1943-0671, Midlands Partnership NHS Foundation Trust, autor de correspondencia), Deanne Burch (Midlands Partnership NHS Foundation Trust), Georges Petitjean (Midlands Partnership NHS Foundation Trust) |
| Año | 2024 |
| Volumen | 21 |
| Número | 12 |
| Páginas | 1605-1605 |
| Fecha de publicación | 2024-11-30 |
| Peer Reviewed | Sí |
| Open Access | Sí |
| Tipo | ARTICLE |
| Revista | International Journal of Environmental Research and Public Health (JOURNAL) |
| Identificadores de la revista | ISSN: 1661-7827 • E-ISSN: 1660-4601 |
| Editorial | Multidisciplinary Digital Publishing Institute (PUBLISHER • CH) |
| DOI | 10.3390/ijerph21121605 |
| PMID | 39767446 |
| OpenAlex | W4404926685 |
| Idioma | EN |
| Referencias citadas | 23 |
The COVID-19 pandemic had wide impacts and repercussions for the NHS in the UK beyond the acute medical sector. This qualitative study evaluates the experience of medical (4) and non-medical prescribers (7) plus other staff (2 recovery workers; 2 community pharmacists) involved in opioid substitution therapy (OST) in a southern English county during and following the COVID-19 pandemic. Remote contact and a shift to predominantly weekly OST pick-up were anxiety-producing for clinicians, especially during the first lockdown. Widespread negative consequences were anticipated, such as a rise in fatal overdoses, which largely failed to materialise. Some diversion of medication was noted as were negative mental health consequences of enforced social isolation. Following a hiatus, psychosocial therapies transitioned to fully digital and subsequently hybrid delivery before returning to in-person group work towards the close of the pandemic. Changing power dynamics between clinicians and those accessing OST services were reported particularly around the re-introduction of daily supervised consumption and associated surveillance. Implications for future OST service delivery and national clinical guidance are suggested by way of conclusions
Anxiety · Coronavirus disease 2019 (COVID-19 · Disease · Family medicine · Medical emergency · Mental health · Pandemic · Psychiatry · Psychosocial · Qualitative research · Social isolation · COVID-19 and Mental Health · Medicine · Migration, Health and Trauma · Nursing · Opioid Use Disorder Treatment
Responding to the opioid crisis in North America and beyond
Understanding and learning from rural drug service adaptations to opioid substitution therapy during the Covid-19 pandemic
Reorganization of Substance Use Treatment and Harm Reduction Services During the Covid-19 Pandemic
Should I Stay or Should I Go? A Qualitative Exploration of Stigma and Other Factors Influencing Opioid Agonist Treatment Journeys
The impact of Covid-19 on access to harm reduction, substance use treatment and recovery services in Scotland
Living Under Coronavirus and Injecting Drugs in Bristol (Lucid-B)
A qualitative study exploring the impact of the Covid-19 pandemic on People Who Inject Drugs (PWID) and drug service provision in the UK
Covid just kind of opened a can of whoop-ass”
Methadone and buprenorphine-related deaths among people prescribed and not prescribed Opioid Agonist Therapy during the Covid-19 pandemic in England
You'll come in and dose even in a global pandemic”
| Velocidad de citación | historical |
|---|---|
| Altamente citado | No |